Quantitative changes in serum proteins including CXCL13 are early indicators of response to anti-IL6 therapy in idiopathic multicentric castleman disease

Category Systematic review
JournalBlood
Year 2019
This article has no abstract
Epistemonikos ID: da8289e242cb1c8782d3cf8fb642e0082070b73e
First added on: Feb 11, 2025